The World Health Organization declared on Monday that Nigeria is free of Ebola, a rare victory in the months-long battle against the fatal disease.
Human testing of an experimental Canadian-made Ebola vaccine began Monday, with federal...
The WHO is finalizing the legal agreement needed for it to take possession of between 800 and 1,...
As West Africa's Ebola outbreak continues to rage, some experts are coming to the conclusion...
The National Institute of Allergy and Infectious Diseases says an experimental Ebola vaccine is being processed at a facility in Frederick. The vaccine is a joint project between the federal agency and GlaxoSmithKline.
The recent deaths of Syrian children after receiving measles vaccinations was the result of a "mistake" by a non-governmental partner who mixed in a muscle relaxant meant for anesthesia, a spokesman for the U.N. secretary-general said Wednesday.
Shares of some companies that are studying potential vaccines for Ebola climbed after federal officials announced that the first case of the disease has been diagnosed in the U.S.
The World Health Organization says there should be thousands of doses of experimental Ebola vaccines available in the coming months and they could eventually be given to health care workers and other people who have had contact with the sick.
The World Health Organization says a vaccine might be available in large enough quantities by the end of the year to help control West Africa's Ebola outbreak.
New estimates from the World Health Organization warn the number of Ebola cases could hit 21,000 in six weeks unless efforts to curb the outbreak are ramped up, according to an analysis published online Tuesday by the New England Journal of Medicine.
The number of Ebola cases could start doubling every three weeks in West Africa, the World Health Organization said Tuesday, warning that the outbreak will cost nearly $1 billion to contain so it does not turn into a "human catastrophe."
High level efforts are underway to find ways to substantially ramp up production of experimental Ebola vaccines and drugs, officials at the World Health Organization and within the U.S. government say.
The Seattle-based foundation said the money will go to the United Nations, the World Health Organization, the U.S. Centers for Disease Control and Prevention and international organizations involved in fighting transmission of the virus.
A fourth American who contracted Ebola in West Africa was expected to arrive in the U.S. for care today and will be treated at an Atlanta hospital where two other aid workers successfully recovered from the disease.
The meeting follows on an earlier consultation during which the WHO asked ethicists and others if it would be ethical to use unlicensed Ebola drugs and vaccines in this unprecedented outbreak. The group, which met in early August, agreed that it was. Since then, much planning and research has gone into trying to prepare this group of advisers to answer questions around who should get drugs or vaccines and under what circumstances.
The Ebola outbreak in West Africa eventually could exceed 20,000 cases, more than six times as many as are now known, the World Health Organization said Thursday. A new plan by the U.N. health agency to stop Ebola also assumes that the actual number of cases in many hard-hit areas may be two to four times higher than currently reported. If that's accurate, it suggests there could be up to 12,000 cases already.
The U.N. health agency recommended Tuesday that nations regulate electronic cigarettes and ban them from use indoors until the exhaled vapor is proven not to harm bystanders.In a report to its 194 member nations, the World Health Organization also called for a ban on sales to minors of the popular nicotine-vapor products.
Japan said Monday it is ready to provide a Japanese-developed anti-influenza drug as a possible treatment for the rapidly expanding Ebola outbreak. Chief Cabinet Secretary Yoshihide Suga said that Japan can offer favipiravir, developed by a subsidiary of Fujifilm Holdings Corp., at any time at the request of the World Health Organization.
The global health agency says it is only interested in pursuing therapies which have been shown to combat Ebola infection in animal studies as it helps countries prepare to use medical tools that are untested in humans.
Scientists are racing to begin the first human safety tests of two experimental Ebola vaccines, but it won't be easy to prove that the shots and other potential treatments in the pipeline really work. There are no proven drugs or vaccines for Ebola, a disease so rare that it's been hard to...
A Canadian drugmaker working on an experimental drug for Ebola said Wednesday that it is not ready to make the treatment available in Africa, despite assurances by international health officials that it is ethical to use untested treatments to fight the deadly outbreak.
The World Health Organization has approved the use of ZMapp, but supplies are extremely limited.
The Ebola outbreak in West Africa is focusing a spotlight on an online tool run by experts in Boston that flagged a "mystery hemorrhagic fever" in forested areas of southeastern Guinea nine days before the World Health Organization formally announced the epidemic.
The World Health Organization said it's ethical to use unproven Ebola drugs and vaccines in the outbreak in West Africa provided the right conditions are met. The U.N. agency issued the statement Tuesday after holding a teleconference with experts Monday to discuss the issue.
The experts — ethicists and representatives of the affected countries and other players involved in the outbreak — are meeting at the request of the World Health Organization to debate whether it is ethical to use experimental Ebola therapies in this epidemic.
Spain has imported a U.S.-made experimental Ebola drug to treat a Spanish missionary priest evacuated from Liberia last week after testing positive for the killer virus. The Health Ministry announced Monday that the ZMapp drug, made by Mapp Biopharmaceutical Inc. of San Diego, was obtained in Geneva this weekend and brought to Madrid to treat Miguel Pajares.
The World Health Organization on Friday declared the Ebola outbreak in West Africa to be an international public health emergency that requires an extraordinary response to stop its spread.
West Africans battling to contain the spread of Ebola will have to wait for months until a potentially life-saving experimental drug used on two Americans infected with the dreaded disease could even be made, officials said. Soldiers in two of the affected countries deployed Thursday to try to stem further spread of the virus.
A World Health Organization official on Thursday urged millions of Muslims making the pilgrimage to Mecca, Saudi Arabia, to exercise basic hygiene as mass gatherings pose risks of spreading the Middle East respiratory syndrome.
- Page 1